Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy
Emily Moore, Morven Millar, Rachel Merrick, Tanja Mueller, Victoria Stark, Lynne Jarvis, Amanj Kurdi, Leanne Hopkins, Stuart McTaggart, Rute Vieira, Marion Bennie, Rachael Wood · 2025
Read Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy by Emily Moore, Morven Millar, Rachel Merrick, Tanja Mueller, Victoria Stark, Lynne Jarvis, Amanj Kurdi, Leanne Hopkins, Stuart McTaggart, Rute Vieira, Marion Bennie, Rachael Wood (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12808125.txt.
Description
Twelve authors present a study from two thousand twenty-five on the safety of anti-seizure medicines in pregnancy. For some of these drugs, the evidence on harm to mother and child is still uncertain. Clinicians must balance seizure control against risks to the pregnancy.
The team followed singleton pregnancies across Scotland conceived over thirteen years. Exposure meant a prescription from just before conception through the pregnancy's end, and seven single drugs were examined by name. Compared with matched unexposed pregnancies, exposed ones showed higher rates of pregnancy loss and of congenital conditions in babies. Rates of developmental concerns in children were also higher.
Catalog record
| CREATOR | Emily Moore, Morven Millar, Rachel Merrick, Tanja Mueller, Victoria Stark, Lynne Jarvis, Amanj Kurdi, Leanne Hopkins, Stuart McTaggart, Rute Vieira, Marion Bennie, Rachael Wood |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |